Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NASPI: NAC vs. Ascorbic Acid for CIN Prevention
NCT00356954Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine, ascorbic acid in contrast-induced nephropathy (CIN), sponsored by Seoul National University Hospital. Started Feb 2005; status: completed.
02
Drugs
acetylcysteineascorbic acid
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00356954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356954.